Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02218, USA.
Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02218, USA.
Drug Alcohol Depend. 2019 Nov 1;204:107537. doi: 10.1016/j.drugalcdep.2019.06.039. Epub 2019 Sep 3.
Medical care, public health, and criminal justice systems encounters could serve as touchpoints to identify and intervene with individuals at high-risk of opioid overdose death. The relative risk of opioid overdose death and proportion of deaths that could be averted at such touchpoints are unknown.
We used 8 individually linked data sets from Massachusetts government agencies to perform a retrospective cohort study of Massachusetts residents ages 11 and older. For each month in 2014, we identified past 12-month exposure to 4 opioid prescription touchpoints (high dosage, benzodiazepine co-prescribing, multiple prescribers, or multiple pharmacies) and 4 critical encounter touchpoints (opioid detoxification, nonfatal opioid overdose, injection-related infection, and release from incarceration). The outcome was opioid overdose death. We calculated Standardized Mortality Ratios (SMRs) and Population Attributable Fractions (PAFs) associated with touchpoint exposure.
The cohort consisted of 6,717,390 person-years of follow-up with 1315 opioid overdose deaths. We identified past 12-month exposure to any touchpoint in 2.7% of person-months and for 51.8% of opioid overdose deaths. Opioid overdose SMRs were 12.6 (95% CI: 11.1, 14.1) for opioid prescription and 68.4 (95% CI: 62.4, 74.5) for critical encounter touchpoints. Fatal opioid overdose PAFs were 0.19 (95% CI: 0.17, 0.21) for opioid prescription and 0.37 (95% CI: 0.34, 0.39) for critical encounter touchpoints.
Using public health data, we found eight candidate touchpoints were associated with increased risk of fatal opioid overdose, and collectively identified more than half of opioid overdose decedents. These touchpoints are potential targets for development of overdose prevention interventions.
医疗保健、公共卫生和刑事司法系统的接触点可以作为识别和干预高风险阿片类药物过量死亡个体的机会。阿片类药物过量死亡的相对风险以及可以通过这些接触点避免的死亡比例尚不清楚。
我们使用来自马萨诸塞州政府机构的 8 个单独链接的数据集,对马萨诸塞州年龄在 11 岁及以上的居民进行回顾性队列研究。对于 2014 年的每个月,我们确定了过去 12 个月中接触到 4 个阿片类药物处方接触点(高剂量、苯二氮䓬类药物联合用药、多名开方医生或多家药店)和 4 个关键接触点(阿片类药物解毒、非致命性阿片类药物过量、与注射相关的感染和出狱)的情况。结果是阿片类药物过量死亡。我们计算了与接触点暴露相关的标准化死亡率比(SMR)和人群归因分数(PAF)。
该队列由 6717390 人年的随访时间和 1315 例阿片类药物过量死亡组成。我们发现,在任何接触点的过去 12 个月暴露率为 2.7%,而在 51.8%的阿片类药物过量死亡中。阿片类药物处方的阿片类药物过量 SMR 为 12.6(95%CI:11.1,14.1),而关键接触点的 SMR 为 68.4(95%CI:62.4,74.5)。致命阿片类药物过量的 PAF 为 0.19(95%CI:0.17,0.21),阿片类药物处方和 0.37(95%CI:0.34,0.39),关键接触点。
使用公共卫生数据,我们发现八个候选接触点与致命阿片类药物过量风险增加相关,并且总共确定了一半以上的阿片类药物过量死亡者。这些接触点是制定阿片类药物过量预防干预措施的潜在目标。